Durvalumab vs Zolpidem

## Durvalumab vs Zolpidem: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Zolpidem**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Zolpidem**: Selective GABA-A receptor alpha-1 subunit agonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Zolpidem — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Zolpidem — C19H21N3O.

**Molecular Weight**: Durvalumab — N/A; Zolpidem — 307.3950 g/mol.

**Type**: Durvalumab — Antibody; Zolpidem — Small molecule.